<DOC>
	<DOCNO>NCT01921296</DOCNO>
	<brief_summary>Many woman breast cancer treat aromatase inhibitor medication develop difficulty sleep fatigue treatment . Some example aromatase inhibitor medication include anastrozole ( Arimidex ) , exemestane ( Aromasin ) , letrozole ( Femara ) . Frequently , sleep pill work well improve sleep . Cyclobenzaprine ( Flexeril ) medication originally develop treat muscle spasm . It may also improve sleep patient chronic pain disorder , fibromyalgia . In study test see cyclobenzaprine bedtime help improve sleep woman treat aromatase inhibitor .</brief_summary>
	<brief_title>Pilot Study Cyclobenzaprine Treatment Sleep Disturbance Aromatase Inhibitor-treated Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Cyclobenzaprine</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<criteria>Female gender , age ≥ 18 , postmenopausal . Histologically proven stage 0III invasive carcinoma breast Initiating receive standard dose aromatase inhibitor therapy ( letrozole 2.5mg daily exemestane 25mg daily anastrozole 1mg daily ) total 48 month AI therapy . Trouble sleep past week . ( After sign informed consent document , subject must also global PSQI score ≥5 ) ECOG performance status 02 ( see Appendix A ) . Known hypersensitivity cyclobenzaprine inactive ingredient Diagnosis sleep apnea currently interfere sleep require CPAP , restless leg syndrome currently interfere sleep require medication , Epworth sleepiness scale &gt; 10 . Subjects history hypothyroidism must stable dose thyroid replacement medicine least 3 month prior enrollment Treatment steroid within 1 month Treatment monoamine oxidase inhibitor ( MAOI ) within 14 day enrollment . Concurrent treatment bupropion , MAO inhibitor , phenothiazine ( include thioridazine ) , selegiline , tramadol , medication know prolong QT interval ( www.azcert.org/medicalpros/druglists/druglists.cfm ) Currently primary psychiatric diagnosis ( schizophrenia , psychosis ) suicidal ideation , history bipolar disorder , seizure disorder Known moderate severe hepatic impairment History congestive heart failure cardiac arrhythmia ( atrial fibrillation ) ; myocardial infarction within past 6 month Uncontrolled narrowangle glaucoma Pregnant breast feed Serious unstable medical condition could likely lead hospitalization course study compromise study participation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Aromatase inhibitor</keyword>
</DOC>